EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Earnings Per Share

300147.SZ Upcoming Earnings (Q1 2025)

Earnings Date: Jun 06, 2025
Consensus EPS: Premium

Current P/E ratio : -5.35
Price (Jun 28, 2024, EOD): ¥3.20

The P/E ratio (price-to-earnings ratio) is a financial metric used to assess a company's stock valuation. It is calculated by dividing the stock price by its earnings per share. A higher ratio suggests higher investor expectations, while a lower ratio may indicate undervaluation. It helps investors evaluate potential investments, but it's essential to consider other factors too.

Last 3 Quarters for 300147.SZ Premium

Below you can see how 300147.SZ performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Earnings Report Demo

FAQ

When is the earnings report for 300147.SZ?
Xiangxue Pharmaceutical Co Ltd (300147.SZ) has scheduled its earnings report for Jun 06, 2025 before the markets open.

What is the 300147.SZ price-to-earnings (P/E) ratio?
300147.SZ P/E ratio as of Jun 28, 2024 (TTM) is -5.35.

What is the 300147.SZ EPS forecast?
The forecasted EPS (Earnings Per Share) for Xiangxue Pharmaceutical Co Ltd (300147.SZ) for the first fiscal quarter 2025 is ¥.

What are Xiangxue Pharmaceutical Co Ltd's retained earnings?
On its balance sheet, Xiangxue Pharmaceutical Co Ltd reported retained earnings of ¥568.86 million for the latest quarter ending Mar 31, 2024.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!

About Xiangxue Pharmaceutical Co Ltd

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China... 300147.SZ Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT